Summary
Generic semaglutide (Apo-Semaglutide, Dr. Reddy's) is approved for Type 2 diabetes in Canada — but doctors can legally prescribe it off-label for weight loss, exactly as they do with brand-name Ozempic. At $114/month vs. $250–500 for Ozempic, the generic makes medically supervised weight loss significantly more affordable for Canadians.
What 'Off-Label' Means — and Why It's Completely Legal
When Health Canada approves a drug, it approves it for specific indications (medical uses). Generic semaglutide received approval for Type 2 diabetes management in adults. However, Canadian physicians are legally permitted to prescribe any approved drug for any use they consider medically appropriate — this is called off-label prescribing. It is standard practice, not a grey area. Thousands of Canadian doctors already prescribe brand-name Ozempic off-label for weight loss every month. The same logic applies to generic semaglutide. Your doctor writes a prescription for 'semaglutide injection' and you fill it with the generic. The off-label use is between you and your physician — the pharmacist dispenses whatever the prescription says.
Key point: Off-label prescribing is legal and common in Canada. Doctors routinely prescribe semaglutide for weight loss regardless of the approved indication.
Who Qualifies for an Off-Label Semaglutide Prescription for Weight Loss?
There is no fixed national standard for off-label prescribing, but most Canadian physicians follow Canadian clinical obesity guidelines when deciding who to treat. You are likely to qualify for an off-label semaglutide prescription if: your BMI is 30 or higher; your BMI is 27 or higher with at least one weight-related health condition (high blood pressure, sleep apnea, high cholesterol, pre-diabetes, PCOS, or osteoarthritis); you have tried lifestyle changes (diet and exercise) with limited long-term success; and you do not have contraindications such as a personal or family history of medullary thyroid cancer, multiple endocrine neoplasia (MEN 2), or pancreatitis. A family physician or nurse practitioner can write this prescription. Telehealth providers (see below) can also issue an off-label semaglutide prescription after a virtual assessment.
Key point: BMI 30+ or BMI 27+ with a weight-related condition is the standard threshold for most off-label semaglutide prescriptions in Canada.
Insurance Reality: Provincial Plans Will Not Cover This
This is the part most people find out the hard way. Provincial drug plans (ODB in Ontario, PharmaCare in BC, NIHB in Alberta, etc.) cover semaglutide only when prescribed for Type 2 diabetes — not for weight loss. This is true for both brand-name Ozempic and generic semaglutide. If you receive an off-label prescription for weight loss and submit it to your provincial plan, it will be rejected. Private insurance through your employer is a mixed picture — some plans cover GLP-1s for weight management with appropriate documentation; others do not. Before starting, call your benefits provider and ask specifically: 'Is semaglutide injection covered for weight management or obesity treatment?' If yes, ask whether prior authorization is required. The realistic out-of-pocket scenario for most Canadians without T2D coverage: $114–150/month for generic semaglutide. This is significantly lower than the $250–500 previously required for Ozempic, making sustained treatment more feasible.
Key point: Provincial drug plans cover semaglutide for T2D only. Most Canadians using it for weight loss pay $114–150/month out of pocket with generics.
Telehealth Providers That Prescribe Generic Semaglutide for Weight Loss
As of late May 2026, several Canadian telehealth platforms have explicitly launched generic semaglutide for weight loss programs — making access faster and cheaper than going through a traditional GP. **PocketPills** (pocketpills.com) is currently the cheapest all-in option: $114/month including consultation, medication, and free home delivery to all Canadian provinces with no dispensing fees. **Hims & Hers Canada** (hims.com/ca) launched a $149/month all-in program in May 2026 — virtual consultation, prescription, and medication bundled. **Felix Health** (felixforyou.ca) launched a dedicated generic semaglutide weight loss program on May 28, 2026 at approximately $150/month with consultation included. **Phoenix Health** and **Raven Health** have announced they are price-matching generic semaglutide, offering Ozempic at the same price as the generic (around $114/month) to remain competitive. When using any telehealth provider, complete the health questionnaire accurately — weight, BMI, related health conditions, and prior weight loss attempts. Most platforms process prescriptions within 24–48 hours and ship directly to your door.
Key point: PocketPills is currently cheapest at $114/mo all-in with free delivery. Hims ($149/mo), Felix ($150/mo), Phoenix, and Raven all offer consultation-included programs competing on price.
What to Expect: Dosing, Timeline, and Results
Generic semaglutide for weight loss uses the same dosing protocol as Ozempic: start at 0.25mg once weekly for 4 weeks, increase to 0.5mg, then to 1mg once you're tolerating it well. For weight loss (not diabetes), physicians sometimes titrate higher — this requires brand-name Wegovy (2.4mg) which is not yet available as a generic. Clinical trials of semaglutide 1mg (the generic dose) in people without diabetes showed approximately 8–10% average body weight loss over 40 weeks. Wegovy (2.4mg) showed approximately 15% average weight loss over 68 weeks — meaningfully more, but at significantly higher cost. Most people start noticing reduced appetite within the first 2–4 weeks. Significant weight loss (5%+ of body weight) is typically seen within 12–16 weeks at effective doses. Side effects — nausea, vomiting, constipation, reduced appetite — are most pronounced during the titration phase and typically diminish after 4–8 weeks. Weight regain after stopping semaglutide is common and significant; most physicians recommend treating obesity as a chronic condition requiring long-term management.
Generic Semaglutide vs. Wegovy for Weight Loss: Is the Cheaper Option Enough?
This is the most common question from people coming off Ozempic or considering GLP-1 therapy for the first time. The honest answer: it depends on your goals. Generic semaglutide at 1mg produces meaningful weight loss — roughly 8–10% of body weight in studies. Wegovy at 2.4mg produces more — roughly 15% of body weight. If your goal is modest weight loss (10–20 lbs) or you have a BMI in the 27–32 range, generic semaglutide at 1mg may be sufficient. If your goal is significant weight loss (30+ lbs) or you have a higher BMI, the extra efficacy of Wegovy may be worth the higher cost — approximately $450–600/month for brand-name Wegovy, or waiting for a generic Wegovy equivalent (not expected until 2027 at the earliest). A practical approach many physicians recommend: start with generic semaglutide at 1mg, evaluate your response at 3 months, and only escalate to Wegovy if you're not achieving adequate results. This keeps costs low while preserving the option to step up.
🍁 What This Means for Canadians
Canada's status as the first G7 country to approve generic semaglutide is particularly significant for weight loss patients, who have historically been excluded from drug plan coverage and forced to pay full price. Obesity Canada estimates over 8 million Canadians live with obesity (BMI 30+), and fewer than 5% have ever been prescribed a GLP-1 medication — primarily due to cost. At $114/month, generic semaglutide is the first GLP-1 drug priced within reach of many Canadians without drug coverage. Provincial drug plans remain slow to add obesity as a covered indication; advocacy groups including Obesity Canada are pushing for formulary changes alongside the generic launch.
Track Generic Semaglutide Prices Across Canada
Our Generic Semaglutide Tracker shows current pricing at 10+ pharmacies and telehealth providers — updated weekly so you know exactly what you'll pay before booking an appointment.
Information on this page is for general informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional before making any healthcare decisions.